The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine
The emergence of a severe acute Sulphur Powder respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19) in China, reported to the World Health Organization on December 31, 2019, has led to a large global pandemic and is a major public health issue.As a result, there are more than 200 clinical trials of COVID-19 treatments or vaccines that are eith